ArticleFrontiers in public health2025
Application of quantitative real-time PCR for identifying respiratory tract pathogens in outpatients with RTIs.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Respiratory tract infections (RTIs) caused by various pathogens, including viruses, bacteria, and fungi, pose significant public health challenges worldwide. Understanding the etiology and epidemiology of RTIs is necessary for clinical management, rational drug use, formulation of preventive measures, and vaccine development. Methods: Quantitative real-time PCR was used to detect and analyze respiratory pathogens in outpatients at a hospital in Suzhou, including FluA, FluB, RSV, ADV, HRV, MP, and SARS-CoV-2. Results: Among the 27,031 respiratory and throat swab samples, the positive rate of virus detection accounts for 25.6%. MP, SARS-CoV-2, and FluA, in particular, showed high positive rates among children, adolescents, and adults. The highest infection rates of RSV, HRV, and ADV were found in patients under 5 years old. High rates of FluA and FluB were observed in patients aged 5-17 and 18-44 years. However, the highest rate of SARS-CoV-2 infection was primarily observed in older adults. Seasonally, the infection rates of SARS-CoV-2 and FluA were highest in spring, FluB, RSV, and ADV in winter, HRV in autumn, and MP in summer and autumn. Conclusion: By analyzing the results of respiratory virus nucleic acid detection, we can gain a better understanding of the infection status of common respiratory viruses, providing a basis for clinical diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.